Pilot Study of COR-1 in Heart Failure

• Status: Completed
• Trial end date: 2013-08-01

Summary

The purpose of this study is to investigate the effect of COR-1 in combination with standard therapy in patients with heart failure. The safety and tolerability of COR-1 will also be assessed.

• Phase: Phase 2

Details

• Lead Sponsor: Corimmun GmbH